14.09.2010 • NewsAmgenCitigroupGoldman Sachs

Amgen Launches $1.5 billion Two-Part Debt Sale

Amgen on Monday launched $1.5 billion of debt in a two-part sale. The offering includes $900 million of 10-year notes expected to yield 77 basis points over comparable U.S. treasuries and $600 million of 31-year bonds expected to yield 117 basis points more than U.S. treasuries.

The joint book managers on the sale are Citigroup, Goldman Sachs and Morgan Stanley.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.